Literature DB >> 3139741

Effect of lysine vasopressin on basal and TRH stimulated TSH and PRL release in normal men.

P Chiodera1, A Gnudi, C Marchesi, G Rossi, L Camellini, A Caiazza, L Bianconi, R Volpi, V Coiro.   

Abstract

In order to test the possible effects of lysine vasopressin (LVP) on basal and TRH stimulated TSH and PRL release, an iv bolus of LVP (0.06 IU/kg bw) was injected alone or just before TRH (20 or 400 micrograms iv) in 18 normal male subjects. The administration of LVP modified neither the basal secretion of TSH and PRL nor the TSH and PRL release induced by 20 or 400 micrograms TRH. These data suggest that in humans, vasopressin is not involved in the control of TSH and PRL release at the anterior pituitary level.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3139741     DOI: 10.1007/BF03350168

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  21 in total

1.  Comparison of the effects of pulsatile and continuous TRH infusion on TSH release in men.

Authors:  J M Hartnell; A E Pekary; J M Hershman
Journal:  Metabolism       Date:  1987-09       Impact factor: 8.694

2.  A homologous radioimmunoassay for human prolactin.

Authors:  Y N Sinha; F W Selby; U J Lewis; W P VanderLaan
Journal:  J Clin Endocrinol Metab       Date:  1973-03       Impact factor: 5.958

3.  Adrenergic control mechanism for vasopressin-induced plasma growth hormone response.

Authors:  S A Heidingsfelder; W G Blackard
Journal:  Metabolism       Date:  1968-11       Impact factor: 8.694

Review 4.  Neuroendocrine control of thyrotropin secretion.

Authors:  J E Morley
Journal:  Endocr Rev       Date:  1981       Impact factor: 19.871

5.  Arginine vasopressin as a thyrotropin-releasing hormone.

Authors:  M D Lumpkin; W K Samson; S M McCann
Journal:  Science       Date:  1987-02-27       Impact factor: 47.728

6.  Cholinergic-muscarinic receptors participate in growth hormone secretion induced by lysine-8-vasopressin in man.

Authors:  V Coiro; R Volpi; P Muzzetto; A Caiazza; R Petrolini; L Cerri; G Ruberti; P Chiodera
Journal:  Horm Metab Res       Date:  1985-06       Impact factor: 2.936

7.  Blood-cerebrospinal fluid barrier to arginine-vasopressin, desmopressin and desglycinamide arginine-vasopressin in the dog.

Authors:  V T Ang; J S Jenkins
Journal:  J Endocrinol       Date:  1982-06       Impact factor: 4.286

8.  Lysine-vasopressin does not affect basal and LH-RH-stimulated LH and FSH release during the menstrual cycle of normal women.

Authors:  P Chiodera; R Volpi; C Cigarini; A Caiazza; C Marchesi; G Rossi; L Camellini; M Guerra; V Coiro
Journal:  Gynecol Obstet Invest       Date:  1987       Impact factor: 2.031

9.  Vasopressin has a direct effect on prolactin release in male rats.

Authors:  S H Shin
Journal:  Neuroendocrinology       Date:  1982-01       Impact factor: 4.914

10.  Effect of an antiserotoninergic drug, metergoline, on the ACTH and cortisol response to insulin hypoglycemia and lysine-vasopressin in man.

Authors:  F Cavagnini; U Raggi; P Micossi; A Di Landro; C Invitti
Journal:  J Clin Endocrinol Metab       Date:  1976-08       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.